酰胺衍生物型手性固定相拆分普萘洛尔对映体

１引言普萘洛尔（ｐｒｏｐｒａｎｏｌｏｌ）是临床使用的一种β－受体阻滞剂，由于其对映体在药理和药物动力学方面存在差异，所以它的拆分工作具有重要意义。本文首次用酰胺衍生物型手性固定相正相直接拆分普萘洛尔对映体，优化了分离条件，拆分过程直接、快速、有效。最后推断了对映体的洗脱顺序。２实验部分２．１仪器与试剂Ｖａｒｉａｎ５０００型液相色谱仪，ＵＶ－１００型紫外可见分光检测器。所用试剂为分析纯（重蒸）。盐酸普萘洛尔（北京第二制药厂）经如下处理：取适量盐酸普萘洛尔，加入２ｍＬ１，２－二氯乙，再加入１ｍＬ１．…     

β－环糊精含硫衍生物自组单分子膜修饰金电极的选择穿透性研究

β－环糊精含硫衍生物自组单分子膜修饰金电极的选择穿透性研究何品刚，方禹之，铃木，嚴长，哲郎（华东师范大学化学系，上海，２０００６２）（东北大学药学部，仙台９８０，日本国）关键词硫辛酰－β－环糊精衍生物，自组单分子膜，金电极近年来，为在分子水平上控制和...     

含羟基芳基或氨基芳基的磷酰胺酯衍生物的合成

采用均相反应的方法合成了6个含羟基芳基或氨基芳基的磷酰胺酯衍生物:[(ClCH_2CH_2)_2NP(O)(OPh)(XArY)](X:O,NH;Y:m或p-OH或NH_2).用元素分析、红外光谱、氢核磁共振谱及质谱证实了它们的组成及结构.     

Zn(Ⅱ)与氯苯基苯并咪唑配合物的合成、表征和晶体结构

带咪唑、苯并咪唑等配位基团的过渡金属配合物是一类很重要的物质[1～ 9] 。本文探讨它与Ｚｎ(Ⅱ )的配位性质及配合物的晶体结构。1　实验部分1 .1　标题配合物的合成及表征将 92ｍｇ 2 (0 氯苯基 )苯并咪唑和 40ｍｇＺｎＣｌ2(ＡＲ)分别溶于无水乙醇(ＡＲ)后混合均匀 ,于室温下静置 3 0天 ,析出长方体形无色晶状物 ,产率为 47%。采用Ｐｅｒｋｉｎ Ｅｌｍｅｒ 2 4 0Ｃ元素分析仪测定配合物中Ｃ、Ｈ、Ｎ含量。用ＤＤＳ 1 1Ｃ数显电导率仪 ,以ＤＭＦ为溶剂测定配合物的摩尔电导。采用Ｎｉｃｏｌｅｔ5ＤＸ Ｂ傅立叶变换红外光谱仪 ,ＫＢｒ压…     

碳纤维微电极研究(Ⅺ)——利用温度效应测定电极反应的热力学和动力学参数

研究了温度对碳纤维微电极上伏安曲线的影响及温度与电极电位的关系,测定了电极反应的热力学参数.由电流与温度的关系测定了去极剂的扩散活化能E_(al)和D_o,利用微电极具有高速传质的特性,测定了常规电极上为可逆反应的电极反应标准速率常数(?),并通过(?)与温度的关系测定了电极反应的活化能.     

Synthesis of 2-Aminochromene Derivatives Catalyzed by KF／Al2O3

A series of 2-aminochromene derivatives including 2-amino-ben-zo[ h ] chromene, 2-amino-benzo [ f ] chromene and 2-amino-pyrano [3,2-h ]quinolin derivatives was synthesized from aryl-aldehyde, malononitrile or ethyl cyanoacetate and 1-naphthol or 2-naphthoi or 8-hydroxyquinoline in refluxing ethyl alcohol cat-alyzed by KF-Al2O3. The structures were confirmed by X-ray analysis.     

Synthesis and Liquid Crystalline Properties of 3-Substituted Pentane-2,4-dione, Pyrazole and Isoxazole Derivatives

The γ-substituted β-diketonate 2,4-dioxo-3-pentyl 4-[4-（n-octyloxy）cinnamoyl]oxybenzoate 1 and its pyrazole and isoxazole derivatives （2 and 3 respectively） have been synthesized and characterized by the spectroscopic methods and elemental analysis. The mesogenic properties of these compounds have been studied by polarizing optical microscopy （POM） and differential scanning calorimetry （DSC）. A monotropic nematic mesophase was observed for the β-diketonate 1, in contrast, the pyrazole 2 displays an enantiotropic smectic A and isoxazole 3 exhibits an enantiotropic nematic mesophase. The relationship between the structure and liquid crystalline properties has also been discussed.     

一个新的噻二唑衍生物H2ADTZ与锰的二维聚合物的合成与晶体结构(英)

A new 1,3,4 thiadiazole-derivative ligand 2,5-(s-acetic acid) dimercapto-1,3,4 thiadiazole (H₂ADTZ) and its one-dimensional manganese polymer Mn(ADTZ)·4H₂O had been synthesized and structurally characterized by X-ray single crystal diffraction in this paper. The Mn(Ⅱ) ion is coordinated with a distorted octahedron by two oxygen atoms from neighboring two deprotonated ligands ADTZ^2- and other four oxygen atoms from four coordinated water molecules. The structural feature of the title compound is the formation of one-dimensional manganese chains polymer through the bridging of dioxygen O-O units. In the solid state structure of the complex, one-dimensional manganese chains are joined together by the weak intermolecular hydrogen bonds and vander Waals interactions forming a two-dimensional supramolecular compound. Furthermore, the UV spectra and electro-chemical properties of the title compound were also investigated. CCDC: 260532.     

末端碳链长度对偶氮苯自组装膜结构的影响

The end-group dominated molecular orientation in the azobenzene self-assembled monolayers (SAMs), CnAzoC2SH (n=1-4), on gold was evaluated for the first time by grazing incidence reflection absorption FTIR spectroscopy (RA-FTIR). All these azobenzene SAMs have highly-organized and closely-parked structures, with the molecule tilting away gradually from surface normal direction with the increase of end group alkyl length.     

高效液相色谱-串联质谱法测定小鼠组织中的新型抗心力衰竭化合物AF-HF001

建立了基于高效液相色谱-质谱联用技术的新型抗心力衰竭化合物AF-HF001在小鼠组织中的测定方法,并考察了其在小鼠体内的组织分布。采用液-液萃取对样品进行预处理,以Thermo Hypersil Gold C18色谱柱进行分离,流动相为乙腈-0.1%甲酸水溶液,梯度洗脱,采用选择性反应监测(SRM)正离子模式检测分析物。小鼠组织中AF-HF001含量在0.5~10μg/mL范围内线性关系良好(r>0.996),在加标量为1.5,4,10μg/mL的组织样品中,提取回收率大于58%,基质效应在100.38%~109.99%之间,日内和日间精密度RSD均小于15%。该方法为AF-HF001的体内分布研究及进一步药物研发提供了依据。初步结果表明,该化合物能够迅速到达心脏并迅速代谢,主要分布在肝脏组织中,其他组织中分布较少。